Your browser doesn't support javascript.
loading
Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma.
Hatano, Takashi; Matsu-Ura, Taishi; Mori, Kei-Ichiro; Inaba, Hiroyuki; Endo, Katsuhisa; Tamari, Mayumi; Egawa, Shin.
Afiliación
  • Hatano T; Department of Urology, JR Tokyo General Hospital, Japan.
  • Matsu-Ura T; Department of Urology, JR Tokyo General Hospital, Japan.
  • Mori KI; Department of Urology, JR Tokyo General Hospital, Japan.
  • Inaba H; Department of Urology, The Jikei University School of Medicine, Japan.
  • Endo K; Department of Urology, JR Tokyo General Hospital, Japan.
  • Tamari M; Research Center for Medical Science Core Research Facilities for Basic Science, The Jikei University School of Medicine, Japan.
  • Egawa S; Department of Urology, The Jikei University School of Medicine, Japan.
Jpn J Clin Oncol ; 49(5): 473-476, 2019 May 01.
Article en En | MEDLINE | ID: mdl-30920617
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Urológicas / Progresión de la Enfermedad / Anticuerpos Monoclonales Humanizados Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Urológicas / Progresión de la Enfermedad / Anticuerpos Monoclonales Humanizados Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article